Here’s what you should know:
1. The attorney generals filed their initial suit in 2016 against several large pharmaceutical companies including Mylan and Teva Pharmaceuticals.
2. The attorney generals are requesting their suit be amended to include at least a dozen new companies.
3. The 12 possible new defendants are: Actavis Holdco; Actavis Pharma; Ascend Laboratories; Apotex Corp.; Dr. Reddy’s Laboratories; Emcure Pharmaceuticals; Glenmark Pharmaceuticals; Lannett Company; Par Pharmaceutical Companies; Sandoz; Sun Pharmaceuticals and Zydus Pharmaceuticals.
4. CNBC reports the companies colluded to raise prices.
5. The states are seeking injunctive relief, civil penalties and disgorgement of profits.
6. Connecticut Attorney General George Jepsen is leading the state coalition.
More articles on coding, billing and collections:
Why revenue cycle needs millennials — and, like, now
Creating a competitive edge at your facility: The patient experience
3 key thoughts on bundles and the ASC space
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
